STATE STREET CORP

Position in CGON — CG Oncology, Inc.

CIK 93751 BOSTON, MA

Position in CGON

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$179,152,614

+$54,729,838 QoQ

Shares Held

2,647,054

-11.7% QoQ

Ownership

3.00%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 12.898414614888853.ToString("F0")% Shared 0.011333353985222817.ToString("F0")% None 87.09025203112593.ToString("F0")%

Healthcare · as of Mar 31, 2026

STATE STREET CORP holds $30,293,122,197 across 420 Biotechnology names. CGON ranks #38 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	11,730,139	$5,237,976,269
2	REGN	Regeneron Pharmaceuticals, Inc.	4,664,478	$3,603,962,281
3	ALNY	Alnylam Pharmaceuticals, Inc.	3,322,698	$1,099,381,087
4	INSM	INSMED Inc	5,551,699	$907,813,820
5	INCY	Incyte Corp	9,641,384	$907,447,062
6	MRNA	Moderna, Inc.	14,861,409	$754,959,577
7	RPRX	Royalty Pharma plc	10,989,851	$527,183,152
8	ROIV	Roivant Sciences Ltd.	16,186,613	$448,369,180

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$179,152,614	2,647,054	-11.7%	Shares	Defined	2026-05-15
2025-12-31	$124,422,776	2,996,695	+46.4%	Shares	Defined	2026-02-13
2025-09-30	$82,439,746	2,046,667	-5.5%	Shares	Defined	2025-11-14
2025-06-30	$56,309,578	2,165,753	+10.1%	Shares	Defined	2025-08-14
2025-03-31	$48,183,805	1,967,489	+2.3%	Shares	Defined	2025-05-15
2024-12-31	$55,168,389	1,923,584	+13.1%	Shares	Defined	2025-02-14
2024-09-30	$64,165,637	1,700,653	+73.0%	Shares	Defined	2024-11-14
2024-06-30	$31,031,131	982,931	+180.2%	Shares	Defined	2024-08-14
2024-03-31	$15,401,480	350,831	—	Shares	Defined	2024-05-15
No filing history on record for this holder in this stock.